Fierce Pharma Engage 2025

In this powerful and deeply personal keynote, a seasoned leader shares hard-earned lessons from three transformative years steering investor relations and communications at a clinical-stage biotech company. From the highest highs of orchestrating a record-setting IPO to the lowest lows of reporting clinical trial failures and the associated organizational impacts, this session offers a candid look at what it takes to navigate the ever-shifting biotech landscape.